Angiotensin Receptor Blockers

PHILADELPHIA — Angiotensin receptor blockers were associated with worse outcomes in patients with celiac disease, including anemia, iron deficiency and “continued mucosal damage in the small intestine,” according to a presenter.

Patients with albuminuric chronic kidney disease without diabetes can experience a significantly increased survival free of kidney failure if treated with the combination of angiotensin receptor blockers and SGLT2 inhibitors.

ORLANDO — Patients with chronic kidney disease did not see a change in kidney function when clinicians continued a course of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, according to a study presented here.

Angiotensin receptor blockers and beta-blockers slow down the expansion of the aorta in patients with Marfan syndrome and no previous aortic surgery, according to data reported at the European Society of Cardiology Congress.

Angiotensin receptor blockers may reduce progression from mild cognitive impairment to dementia in patients undergoing antihypertensive treatment, researchers wrote in Hypertension.

Use of angiotensin receptor blockers was associated with less need for ventilation and vasopressors among men hospitalized with COVID-19, but not in women, according to research presented at the Society of Critical Care Medicine Congress.

A resistance exercise program was superior to an aerobic exercise program in improving sleep quality and duration in adults with hypertension, according to a recent study.

Angiotensin receptor blockers don’t significantly differ compared with ACE inhibitors as first-line treatment for patients with hypertension, but do present with a better safety profile, researchers reported.

Among veterans with HIV and new-onset hypertension, beta-blockers were independently associated with increased risk for incident CVD or death compared with ACE inhibitors or angiotensin receptor blockers, researchers reported.

Safety assessment of ACE inhibitors and angiotensin receptor blockers in patients with high BP and COVID-19.